ArticleObesity surgery2026
Remnant Gastrectomy as a Pathophysiology Based Treatment of Marginal Ulcer after Roux-en-Y Gastric Bypass: A Retrospective Clinical Series of 41 Patients.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMarginal ulcer (MU) is a typical complication after gastric bypass with reported frequencies from < 1% to 25%. The first line therapy is almost invariably acid reduction by proton pump inhibitors (PPI). In case of complicated MU, revision of the anastomosis is the most frequent surgical treatment, while surgical acid reduction is addressed only rarely. We present the rationale of treating MU by surgical acid reduction and report the results of 41 cases. MATERIALS AND
methodsG-cell ablation as a reduction of acid stimulation was achieved by remnant gastrectomy (RG). Only if necessary, pouches were reshaped and anastomoses revised. Results were controlled by fluoroscopy on day 2 after surgery. Postoperative controls were carried out after 6 and 12 weeks, 6 and 12 months and in yearly intervals.
resultsFrom February 2018 to March 2025 37 women and 4 men underwent RG. RG was a stand-alone procedure in 14 patients. Only 16 patients underwent revision of their anastomoses. All patients were alive 90 days after surgery and 38 were available for follow up. The median length of hospital stay was 5 days (2–48). Symptoms (vomiting, pain, food intolerance, weight loss) resolved in all cases. Endoscopic control was performed in only 7 patients, therefore the evidence of non-recurrence was mainly based on clinical symptoms.
conclusionRG is based on the pathophysiology of acid production. The results are promising with tolerable complication rates. We suggest to consider the procedure as treatment for complicated MU. • Vagotomy of the remnant stomach due to pouch creation causes local hypoacidity • Lack of parietal cells causes antral hypoacidity in revisional bypass • Subsequent gastrin stimulation increases pouch acidity and causes MU • RG ablates the excess gastrin stimulation and allows healing of MU
Indexed as
Identifiers
42000988What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.